Podcasts about Barzilai

In this episode, we dive deep into the science of aging with longevity expert Dr. David Barzilai. You've probably seen people online claiming to have reversed their biological age—but is any of that actually possible? We unpack the truth behind biological age tests, anti-aging supplements, and the wildest longevity trends (yes, even blood transfusions from your kids). Dr. Barzilai explains what really works—spoiler: it's not $2 million worth of pills—and shares simple, science-backed ways to live healthier for longer. If you want to cut through the hype and get real about living better, this episode is a must-listen.About Dr. Barzilai: Dr. David Barzilai is a physician and the CEO of Healthspan Coaching LLC. He is a founding faculty member and Trustee at the Geneva College of Longevity Science, and serves as a lecturer at Harvard Medical School. Board-certified in lifestyle medicine, Dr. Barzilai holds both an MD and a PhD in health services research.Find him on X here or connect with him here. Sign up for our newsletter here!For weekly episodes, come join the Foodie Fam!Check out our book!Chat with us on IG @foodweneedtotalk!Be friends with Juna on Instagram and Tiktok! Learn about your ad choices: dovetail.prx.org/ad-choices

Tamir Barzilai is a Vancouver-based entrepreneur building in the crossroads of food and AI. After a diagnosis of an incurable gut disease, he co-founded Honeycomb AI, a company dedicated to food transparency at restaurants, helping over 1.5 million people with dietary needs find suitable food to eat. Aside from tech, Tamir is a writer and avid reader - he hosts his own show called Nectar of Time, synthesizing wisdom and philosophy from unique fiction and non-fiction sources.FOLLOW: tamirbarzilai  Substack: https://substack.com/@kelsisherenWatch on YouTube: https://bit.ly/3opNURn  - - - - - - - - - - - -SUPPORT OUR SPONSORS - - - - - - - - - - - -RHO Nutrition - Code: KELSI20 -  https://rhonutrition.com/KELSIXX-XY Athletics - Code: KELSI20 - https://www.xx-xyathletics.com/?sca_ref=7336247.FtJS2YUK4OKetone IQ- 30% off with code KELSI - https://ketone.com/KELSIGood Livin- 20% off with code KELSI - https://www.itsgoodlivin.com/?ref=KELSIBrass & Unity - 20% off with code UNITY - http://brassandunity.com - - - - - - - - - - - - -SHOPB&U Jewelry & Eyewear: https://brassandunity.com - - - - - - - - - - - - -Follow #thekelsisherenperspective- - - - - - - - - - - - -CHARITYHeroic Hearts Project - https://www.heroicheartsproject.orgHonour House Society - https://www.honourhouse.caAll Secure Foundation - http://allsecurefoundation.orgDefenders of Freedom -https://www.defendersoffreedom.usBoot Campaign - https://bootcampaign.org

Send us a textIn this fascinating episode, Dr. Debbie Ozment, DDS, sits down with Dr. Nir Barzilai, a leading researcher in aging, to explore the science behind longevity and what truly influences our health as we age.Dr. Barzilai explains why biological age—rather than chronological age—is the key factor in determining health and lifespan. He discusses how aging drives diseases and how targeting aging at a biological level could help prevent many chronic conditions.The episode explores the interconnected hallmarks of aging, including metabolism, inflammation, immunity, epigenetics, and the microbiome. Dr. Barzilai highlights how addressing any of these hallmarks can positively affect others, paving the way for healthier aging.Dr. Barzilai also discusses the role of metformin, not as a miracle cure but as proof that aging can be targeted. He shares insights into its potential benefits beyond glucose control, such as its effects on immunity and inflammation.Beyond medications, he emphasizes the importance of lifestyle choices, such as exercise, diet (including intermittent fasting), sleep, and social connectivity, in slowing down the aging process. He shares his personal habits and the wisdom he has gathered from studying centenarians.Looking ahead, Dr. Barzilai is focused on advancing research to measure biological age through biomarkers and protein analysis. He also explores emerging discoveries, such as the impact of stress as a new hallmark of aging and the influential role of social connections in extending lifespan.Tune in to discover the latest scientific breakthroughs in aging and practical strategies to enhance your healthspan!Visit my website DrDebbieOzment.com for valuable free downloads. Additionally, you will find shopping links which I have curated on the website. Please follow me on instagram at drdebbieozment.

Can personalized medicine unlock the secrets to living longer and healthier lives? In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. David Barzilai, a renowned longevity physician and founder of Barzilai Longevity Consulting, to explore the science of extending healthspan through precision and innovation.Dr. Barzilai shares his journey into biogerontology and longevity science, unpacking key concepts like the hallmarks of aging, the potential of lifestyle interventions, and the translation of findings from animal models to human health. He highlights how evidence-based lifestyle medicine—centered on nutrition, exercise, sleep, and stress management—can be tailored to individual needs using biomarker-driven strategies for maximum impact.The conversation delves into some of the most promising longevity interventions, from gerotherapeutics to cutting-edge supplements. Dr. Barzilai emphasizes the power of personalized approaches in optimizing healthspan and lifespan, offering listeners practical, science-backed insights to take charge of their longevity journey.Engaging and informative, this episode is essential listening for anyone curious about the future of longevity medicine and the innovations shaping how we age. Guest-at-a-Glance

David wants to return kindness to Barzilai from Gilad, who took care of David when he fled Jerusalem to the east bank.

In this special episode you will have an opportunity to learn about the key factors to not only living longer but better and higher quality lives from a global expert and pioneer researcher in longevity medicine, Dr. David Barzilai. David provided an update of the landscape in this field as a keynote speaker at the 3rd annual Medical Affairs Innovation Olympics held in October. David is CEO and founder of Healthspan Coaching, LLC., and agingdoc.com, providing longevity medicine and lifestyle consulting. Dr. Barzilai is a Diplomate at the American Board of Lifestyle. He is board-certified in dermatology, with a PhD focused on evidence-based medicine, and also holds an MBA. In his keynote presentation, Dr. Barzilai critically addresses the gaps in treating only one disease at a time and provides alternative methods that target root, underlying causes of disease that can prevent multiple chronic diseases and lengthen the human Healthspan. David challenges the healthcare community and Medical Affairs function in pharma and biotech with a call to action to prioritize efforts to improve healthspan and transform medicine. 0:00 Timeline 0:09 Episode Highlight + Call to Action 1:30 Host Introduction of the Episode 4:17 Keynote Speaker's Presentation Overview 5:04 Dramatic Increase in Global Aging Population 6:10 Gray Tsunami Economic Impact - Rising Health Expenditures 7:07 Healthspan must accompany lifespan increase - Holy Grail of Longevity 7:41 Targeting the Bioscience of Aging: The Geroscience Hypothesis 8:21 12 Hallmarks of Aging 9:29 Problem with Current Approach of Targeting 1 Disease at a Time 10:26 Aging can be manipulated across different species Rapamycin increased lifespan even after being injected in middle aged humans 12:22 Growing Frontier in Longevity Biotech Number of biotech companies have grown from 20 to 50 since 2020 13:57 Lifestyle Medicine as Longevity Foundation 15:12 Global Strategy for Healthy Longevity Global Roadmap to Healthy Longevity National Academy of Medicine - Goal to Increase Lifespan by 6 years by 2030 15:47 Hevolution Foundation - $1 billion investment to accelerate in aging research 16:31 Bridging the gap between biotech and public health initiatives Immediate reforms in healthcare are needed such as compression of morbidity 17:13 Tackle Urgent Challenges of Aging where health is not just preserved but extended Call to Action Integrate Biotech and Public Health Strategies Invest in Aging BIology Train Physician Workforce Promise of Geroscience 19:09 Q & A 20:10 Questions: Roles of 1) Neuralink + 2) Telehealth on Longevity 21:07 Role of Telehealth - know your target audience/sub-specialization is a key factor 22:24 Neuralink comments - exponential increase of dementia

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare. We met with Dr. Nir Barzilai, director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity.  Treatments for age-related diseases like type 2 diabetes are being developed based on Dr. Barzilai's work and are currently in clinical trials. In addition to his “longevity gene” research, Dr. Barzilai studies key mechanisms involved in the biology of aging, including how nutrients and genetics influence lifespan. He is also investigating the physical and mental declines associated with aging and how they affect longevity. Dr. Barzilai is professor of medicine (endocrinology) and of genetics, a member of the Diabetes Research Center, and director of the Diabetes Research and Training Center's Animal Physiology core. Podcast Highlights: Introduction & Dr. Nir Barzilai's Groundbreaking Discovery (00:00 - 03:15): Overview of Dr. Nir Barzilai's discovery of the first “longevity gene” in humans and its link to healthy aging. Discussion on the significance of high HDL cholesterol and how it relates to extreme longevity. The Science Behind Longevity Genes (03:16 - 08:32): Dive into the specific genetic markers that contribute to longevity. Dr. Barzilai shares insights on the mechanisms of aging and the potential to delay or reverse age-related diseases. Current Clinical Trials on Age-Related Diseases (08:33 - 12:10): An exploration of the treatments for type 2 diabetes and other age-related conditions that are being developed from Dr. Barzilai's research, with an update on the progress of these clinical trials. Nutritional and Genetic Influence on Lifespan (12:11 - 17:48): How both genetics and nutrition shape our healthspan and longevity. Dr. Barzilai explains the latest findings on how diet can influence aging and the role of genetics in extending life. Mental and Physical Decline in Aging (17:49 - 21:22): Discussion on the common declines in physical and mental health with aging, and how they impact longevity. Dr. Barzilai talks about ongoing research into mitigating these declines. Future of Longevity Research (21:23 - 26:55): Dr. Barzilai shares his vision for the future of aging research, focusing on potential breakthroughs in longevity science. Social Media: @NirBarzilaiMD: https://x.com/nirbarzilaimd?lang=en  https://www.linkedin.com/in/nir-barzilai-7a86a7212/  Other Links/Mentions/Resources: Age Later by Nir Barzilai, M.D. https://us.macmillan.com/books/9781250230867/agelater  Albert Einstein College of Medicine https://einsteinmed.edu/faculty/484/nir-barzilai  American Federation for Aging Research (AFAR) https://www.afar.org/ Aging is a Treatable Condition - Worth.com The 4 most promising anti-aging drugs investors are sleeping on, according to a leading longevity researcher - Business Insider What is your Biological Age? - The New York Times Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com.

1020 Barzilai nega o convite de David. Ciclo Tanach

Como cristianos, debemos reconocer la importancia de ser amigos leales y generosos, especialmente en tiempos de necesidad. 2 Samuel 17:27-29 Iglesia Bautista de Santa Ana Pastor Ringo Ayala http://santaanabaptist.org Contactenos en: santaanabaptist@gmail.com Recursos: https://payhip.com/ContendiendoPorlaFe

Tamir Barzilai is the CEO and co-founder of Honeycomb.ai, a company dedicated to building the next gen for food discovery for people with dietary restrictions. His company is pioneering an end-to-end dietary pipeline from restaurants to aggregators to consumers, powered by their in-house AI model called RAMS-E. Tamir has spent the last decade working in FoodTech, working with small mom and pop restaurants, to national chains, to Fortune 500 level food companies. After being diagnosed with Ulcerative Colitis, he set out to make ingredient transparency the norm rather than the exception. To date, Honeycomb.ai has helped over 1 million people find suitable food across their product-line. Download the Honeycomb app at get.honeycomb.aiConnect with TamirEmail: tamir@honeycomb.aiInstagramDiscounts Get 10% off delicious local farm-fresh food delivered to your door with my link for FarmMatch: https://farmmatch.com/jane Get 15% off high-quality Italian olive oil with code FARMTOFUTURE: https://shop.vignolifood.com/FARMTOFUTURE Get 40% the CircleDNA's Premium DNA test with code JANEZHANG: https://circledna.com/premium Connect with Jane Z. on Instagram at @farm.to.future

Aaron Barzilai has a Stanford PhD and has worked for multiple NBA teams. He has also founded HerHoopStats.com, a comprehensive site for women's college basketball and WNBA analytics, and joins the show to discuss the 2024 Final Four. Highlights include: South Carolina, coach Dawn Staley vs North Carolina State (0:42). Iowa vs Connecticut (8:50). Offensive, defensive efficiency for Final Four contenders (12:56). Stanford PhD to the NBA (17:34). The origins of HerHoopStats (24:40). The growth in women's basketball (32:32). The Football Analytics Show is presented by The Power Rank, a site devoted to predictive analytics for football betting. To get 5-Nugget Saturday, a curated list of bets and analytics, sign up for the free newsletter here: https://thepowerrank.com/

Durante mucho tiempo se conoció a la ciudad griega de Tesalónica como la Jerusalén de los Balcanes. Allí estaba el principal cementerio judío de Europa, un cementerio que fue confiscado y destruido por los nazis en 1942 y cuyas lápidas fueron luego diseminadas y reutilizadas para la construcción de la ciudad después de la Segunda Guerra Mundial. Una historia que acaba de rescatar en el libro ‘Cimetière Fantôme' (Cementerio Fantasma) el fotógrafo franco-uruguayo Martín Barzilai.

¿Sabían que durante mucho tiempo se conocía a la ciudad griega de Tesalónica como la Jerusalén de los Balcanes? Allí estaba el principal cementerio judío de Europa, un cementerio que fue confiscado y destruido por los nazis en 1942 y cuyas lápidas fueron luego diseminadas y reutilizadas para la construcción de la ciudad después de la Segunda Guerra Mundial. Una historia que acaba de rescatar en el libro ‘Cimetière Fantôme' (Cementerio Fantasma) el fotógrafo franco uruguayo Martín Barzilai. “No quedó nada en Tesalónica”, le solía decir su abuelo León refiriéndose al cementerio que fue arrasado por los nazis. Un cementerio en el que había 300.000 tumbas, el más grande de Europa, y entre esas tumbas se encontraban las de sus ancestros.Martín Barzilai decidió ir en busca de los restos de ese cementerio cuyas lápidas fueron diseminadas por toda la ciudad y usadas como material de construcción.Todo partió de unas fotos que su padre encuentra cuando su abuelo muere. Unas fotos tomadas en los años 20 ó 30 en el cementerio judío de Tesalónica en el que se ve a Mamoute en el cementerio judío junto a la tumba de su hermana Doudoune fallecida en 1926.El cementerio fue construido sobre los restos de un cementerio bizantino, la tumba más antigua que fue descifrada data de 1493, en esa época hubo una llegada masiva a esa ciudad, entonces bajo el Imperio Otomano, de judíos sefarditas que habían sido expulsados de España por los Reyes Católicos. A finales del siglo XIX, el 80% de la población de Tesalónica era judía.Complicidad de las autoridades localesSu historia se borró con la destrucción por los nazis del cementerio judío en 1943 y la deportación a campos de exterminio de 45.000 personas. Los nazis tenían el objetivo de exterminar a los judíos, pero las autoridades locales querían agrandar la ciudad por lo que no pusieron mucho impedimento para que se destruyera.“Es mucha gente, desde Francia se deportaron a 75.000 judíos desde todo el territorio francés. En ese entonces Tesalónica era una ciudad que quizás tenía la dimensión de Marsella”, explica el fotógrafo.“Quiero encontrar lo que volvieron invisible, las huellas que han resistido al tiempo”, escribe Barzilai en el libro. Y en octubre de 2018 viaja allí en busca de esas huellas. El cementerio ya no existe, en su lugar hay un campus universitario de la Universidad Aristóteles.Hay tres personas claves que van a ayudarle a entender la historia borrada de los judíos de Tesalónica y encontrar los restos de las lápidas. Se trata de Jacky Benmayor, especialista de los judíos españoles y de la historia judía de Tesalónica, Iosif Vaena, que es un farmacéutico y Leon Saltiel, historiador y coordinador de la lucha contra el antisemtismo del Consejo judío.“Benmayor me cuenta que las lápidas están diseminadas en la ciudad y que sirvieron para la reconstrucción después de la guerra, para reconstruir iglesias, para construir muros municipales de la nueva estación de trenes, por ejemplo, y otros lugares también privados”, explica el autor del libro donde publica testimonios que cuentan que incluso se usaron lápidas del cementerio judío para hacer mesas de disección para la Facultad de Medicina de la Universidad.“El lugar que más me impresionó es la iglesia más grande que hay en Tesalónica, que se llama San Demetrio y la explanada delante del templo está hecha, según los historiadores con tumbas del cementerio judío”, dice Barzilai.¿Qué pasó con los cuerpos? Algunos fueron rescatados y almacenados en bolsas en una fábrica, gracias a familiares de uno de sus entrevistados, Jacky Benmayor.“Escondieron esos restos durante los años de la guerra y cuando pudieron volver a la ciudad después, muchas veces, de haber sido deportados a Auschwitz y haber sobrevivido a esa experiencia tan terrible, recuperaron los restos y los pusieron en un nuevo cementerio judío que está en las afueras de la ciudad, que es mucho más pequeño”, explica Barzilai.En los viajes que hizo a Tesalónica no encontró las lápidas de sus ancestros, pero queda mucho por descubrir ya que, según algunos testimonios, hay lápidas incluso en el mar. “Me contaron de cuatro lugares donde hay ese tipo de lápidas. Este libro es el principio”, asegura Barzilai. 'Cimetière Fantôme' fue publicado por Créaphis éditions. 

¿Sabían que durante mucho tiempo se conocía a la ciudad griega de Tesalónica como la Jerusalén de los Balcanes? Allí estaba el principal cementerio judío de Europa, un cementerio que fue confiscado y destruido por los nazis en 1942 y cuyas lápidas fueron luego diseminadas y reutilizadas para la construcción de la ciudad después de la Segunda Guerra Mundial. Una historia que acaba de rescatar en el libro ‘Cimetière Fantôme' (Cementerio Fantasma) el fotógrafo franco uruguayo Martín Barzilai. “No quedó nada en Tesalónica”, le solía decir su abuelo León refiriéndose al cementerio que fue arrasado por los nazis. Un cementerio en el que había 300.000 tumbas, el más grande de Europa, y entre esas tumbas se encontraban las de sus ancestros.Martín Barzilai decidió ir en busca de los restos de ese cementerio cuyas lápidas fueron diseminadas por toda la ciudad y usadas como material de construcción.Todo partió de unas fotos que su padre encuentra cuando su abuelo muere. Unas fotos tomadas en los años 20 ó 30 en el cementerio judío de Tesalónica en el que se ve a Mamoute en el cementerio judío junto a la tumba de su hermana Doudoune fallecida en 1926.El cementerio fue construido sobre los restos de un cementerio bizantino, la tumba más antigua que fue descifrada data de 1493, en esa época hubo una llegada masiva a esa ciudad, entonces bajo el Imperio Otomano, de judíos sefarditas que habían sido expulsados de España por los Reyes Católicos. A finales del siglo XIX, el 80% de la población de Tesalónica era judía.Complicidad de las autoridades localesSu historia se borró con la destrucción por los nazis del cementerio judío en 1943 y la deportación a campos de exterminio de 45.000 personas. Los nazis tenían el objetivo de exterminar a los judíos, pero las autoridades locales querían agrandar la ciudad por lo que no pusieron mucho impedimento para que se destruyera.“Es mucha gente, desde Francia se deportaron a 75.000 judíos desde todo el territorio francés. En ese entonces Tesalónica era una ciudad que quizás tenía la dimensión de Marsella”, explica el fotógrafo.“Quiero encontrar lo que volvieron invisible, las huellas que han resistido al tiempo”, escribe Barzilai en el libro. Y en octubre de 2018 viaja allí en busca de esas huellas. El cementerio ya no existe, en su lugar hay un campus universitario de la Universidad Aristóteles.Hay tres personas claves que van a ayudarle a entender la historia borrada de los judíos de Tesalónica y encontrar los restos de las lápidas. Se trata de Jacky Benmayor, especialista de los judíos españoles y de la historia judía de Tesalónica, Iosif Vaena, que es un farmacéutico y Leon Saltiel, historiador y coordinador de la lucha contra el antisemtismo del Consejo judío.“Benmayor me cuenta que las lápidas están diseminadas en la ciudad y que sirvieron para la reconstrucción después de la guerra, para reconstruir iglesias, para construir muros municipales de la nueva estación de trenes, por ejemplo, y otros lugares también privados”, explica el autor del libro donde publica testimonios que cuentan que incluso se usaron lápidas del cementerio judío para hacer mesas de disección para la Facultad de Medicina de la Universidad.“El lugar que más me impresionó es la iglesia más grande que hay en Tesalónica, que se llama San Demetrio y la explanada delante del templo está hecha, según los historiadores con tumbas del cementerio judío”, dice Barzilai.¿Qué pasó con los cuerpos? Algunos fueron rescatados y almacenados en bolsas en una fábrica, gracias a familiares de uno de sus entrevistados, Jacky Benmayor.“Escondieron esos restos durante los años de la guerra y cuando pudieron volver a la ciudad después, muchas veces, de haber sido deportados a Auschwitz y haber sobrevivido a esa experiencia tan terrible, recuperaron los restos y los pusieron en un nuevo cementerio judío que está en las afueras de la ciudad, que es mucho más pequeño”, explica Barzilai.En los viajes que hizo a Tesalónica no encontró las lápidas de sus ancestros, pero queda mucho por descubrir ya que, según algunos testimonios, hay lápidas incluso en el mar. “Me contaron de cuatro lugares donde hay ese tipo de lápidas. Este libro es el principio”, asegura Barzilai. 'Cimetière Fantôme' fue publicado por Créaphis éditions. 

Unlock the mysteries of aging with our fascinating guest, Dr. Nir Barzilai, as we embark on a journey through the science of longevity. This episode promises to reveal the biological secrets that could redefine your approach to living a long, healthy life. Dr. Barzilai, with his wealth of knowledge, decodes the process of antagonistic pleiotropy where the very mechanisms that protect us in youth may become our foes in old age. Together we scrutinize inflammation's role in aging, explore the intertwining of nutrition and longevity, and ponder the potential of targeting aging to preempt age-related diseases. Our conversation navigates through the nuances of intermittent fasting and the surprising health benefits of a 16:8 fasting routine, offering personal insights and strategies that have become integral to our lives.Some of the topics we will discuss are:- Secrets of Longevity- Tips on how to slow down aging- Does intermittent fasting help with longevity?When it comes to the tapestry of longevity, the threads are as complex as they are colorful. Dr. Barzilai sheds light on the unexpected shifts in personality among centenarians and the enigmatic cerebellum, which suggests a mind-boggling 400-year lifespan prediction according to epigenetic markers. We traverse the landscape of aging biomarkers, debating the merits of proteomics over methylation and the transformative potential of metformin beyond its conventional uses. The episode is studded with revelations—from the role of the TAME trial in ushering in a new era of gerotherapeutics to the promise held by mitochondrial derived peptides and hyperbaric oxygen therapy. This is the frontier of science where the aging process itself is the adversary we learn to outmaneuver.Lastly, we venture into the realm of personal health strategies, where sleep, fasting, and the judicious use of supplements play starring roles. With Dr. Barzilai's guidance, we confront the challenges of achieving ketosis and navigate the complexities of the supplement industry in search of reliable data. Through the lens of the Healthy Longevity Medicine Society, we glimpse into the future of longevity biotech—a future rife with opportunities for both medical professionals and investors. This episode isn't merely a treasure trove of information; it's a call to action for anyone intent on curating a healthier, more vibrant life. Join us as we map out the steps toward not just a longer*** CONNECT WITH ROB ON SOCIAL MEDIA ( 250k++)*** Web: https://robertlufkinmd.com/X: https://x.com/robertlufkinmdYoutube: https://www.youtube.com/RobertLufkinMDInstagram: https://www.instagram.com/robertlufkinmd/LinkedIn: https://www.linkedin.com/in/robertlufkinmd/Facebook: https://www.facebook.com/robertlufkinmd Threads: https://www.threads.net/@robertlufkinmd *** SPONSORSHIPS & BRANDS ***We do work with sponsors and brands. If you are interested in working with us for your health industry product or service, please contact us at: https://www.robertlufkinmd.com/contact/NOTE: This is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have. Never disregard professional medical advice or delay in seeking it becaus...

Aging is inevitable, but can we influence how we age? In this episode of Longevity by Design, hosts Dr. Gil Blander and Ashley Reaver, MS, RD, CSSD,  interview Dr. Nir Barzilai—the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging—during which he discusses groundbreaking research on aging. This is an enlightening discussion with Dr. Barzilai on factors influencing healthspan and lifespan, and the paradigm-shifting idea of targeting aging to extend healthspan and lifespan. He shares fascinating insights from his research on the influence of genetics and lifestyle on healthspan and lifespan, and blood biomarkers of aging. The conversation sheds light on the emerging scientific evidence and paradigm-shifting concept for medical interventions (gerotherapeutics) to extend healthspan and lifespan by targeting the underlying biology of aging.The episode wraps up with actionable insights for listeners interested in enhancing their healthspan and longevity. Dr. Barzilai discusses the importance of personalized health strategies, integrating cutting-edge research with everyday health practices while emphasizing the importance of a holistic approach. As a listener, you will leave equipped with knowledge and science-backed ways to navigate your personal health journey and help you live healthier longer.Timestamps:Introduction: 00:00-04:13Why Dr. Barzilai's studies centenarians and their children?: 04:14-10:07 Do centenarians live longer with poor health or live healthier longer? 10:08-13:07Does becoming a centenarian have a strong genetic influence?: 13:08-15:41How do growth hormone and IGF-1 affect healthspan and lifespan?: 15:32-23:39What other genes affect healthspan and lifespan?: 23:40- 26:51Does low IGF-1 negatively impact muscle and physical functioning?: 26:52-28:40What are the effects of ethnicity and socioeconomic status on longevity: 28:41-30:57What is the effect of lifestyle, nutrition, and exercise on the longevity of centenarians?: 30:58-34:07Do women or men live longer?: 34:08-37:55Why do women live longer than men?: 37:56-41:38Biomarkers of aging and biomarkers of organ aging: 41:39-47:07What is metformin, and what is the purpose of the TAME trial?: 47:08-51:37Do you think metformin will improve healthspan and lifespan?: 51:38-54:20Does metformin only improve blood glucose control, or does it benefit health and aging in other ways? 54:21-56:50Is metformin good for older adults but not young adults?: 56:51-57:45How does the combination of metformin and exercise impact muscle size (hypertrophy) and strength?: 57:46-01:00:45Should everyone take metformin?: 01:00:46-01:03:13Dr. Gil Blander's and Dr. Nir Barzilai's personal humorous anecdotes on exercise: 01:03:14-01:04:32Is there a reason and explanation for why metformin did not show an effect on lifespan in mice in the Interventions Testing Program (ITP)?: 01:04:33-01:07:01Are GLP-1 agonists beneficial for healthspan and lifespan?: 01:07:02-01:10:55Are there tradeoffs with using GLP-1 agonists?: 01:10:56-01:11:43What are the top 5 gerotherapeutic candidates for improving healthspan and lifespan?: 01:11:44-01:15:10Dr. Nir Barzilai's top tip for improving health: 01:15:11-01:19:29

View the Show Notes For This EpisodeGet Free Weekly Health Tips from Dr. HymanSign Up for Dr. Hyman's Weekly Longevity JournalGet Ad-free Episodes & Dr. Hyman+ Audio ExclusivesDr. Nir Barzilai is a geroscientist, Chaired Professor of Medicine and Genetics, and the founder and principal investigator of the Einstein Nathan Shock Center and the Glenn Center for Excellence in Biology of Aging. He also studies families of centenarians that have provided genetic and biological insights on the protection against aging—with several drugs developed based, in part, on these paradigm-changing studies. He is also leading the TAME (Targeting/Taming Aging with Metformin) trial to prove to the FDA that aging can be delayed and to allow for next-generation interventions. This episode is brought to you by Sunlighten, Cozy Earth, BiOptimizers, and Fatty 15.For a limited time, you can save up to $600 on a Sunlighten infrared sauna. Just go to sunlighten.com/mark-hyman and mention my name.Right now, you can save 40% when you upgrade to Cozy Earth sheets. Just head over to CozyEarth.com and use code DRHYMAN.Tackle an overlooked root cause of stress with Magnesium Breakthrough. Visit bioptimizers.com/hyman and use code HYMAN10 to save 10% and get a free gift with purchase.Fatty15 contains pure, award-winning C15:0 in a bioavailable form. Get an exclusive 10% off a 90-day starter kit subscription. Just visit Fatty15.com and use code DRHYMAN10 to get started.In this episode we discuss (audio version / Apple Subscriber version):The hallmarks of aging (9:01 / 7:10)What causes the hallmarks of aging? (15:40 / 13:49)Dr. Barzilai's research on centenarians (23:16 / 21:25)Why living to 100+ years is good for the economy (24:54 / 23:03)What enables someone to live to 100 years old? (29:30 / 25:20)Taking growth hormone and Metformin have different effects based on your age (36:58 / 32:48)The connection between HDL cholesterol and longevity (43:36 / 39:26)Dr. Barzilai's research on Metformin (56:23 / 52:13)How Metformin works in the body and on muscle growth (1:04:51 / 1:00:41)Dr. Barzilai's personal longevity (1:42:05 / 1:37:55)Learn more about the Longevity Genes Project and the TAME Trial. Get a copy of Age Later: Health Span, Life Span, and the New Science of Longevity Hosted on Acast. See acast.com/privacy for more information.

LA HISTORIA DEL EY DAVID- 07- DAVID Y BARZILAI- NO SEAS MALAGRADECIDO by Rab Shlomo Benhamu

Dr. Sofiya Milman, MD, MS ( https://www.einsteinmed.edu/faculty/12865/sofiya-milman/ ) is an Associate Professor of Medicine in the Division of Endocrinology and Geriatrics, and is the Director of Human Longevity Studies at the Institute for Aging Research, at Albert Einstein College of Medicine. Dr. Milman's research focuses on a unique population of centenarians and their families ( https://www.superagersstudy.org/ ) who are generally free of age-related diseases, where extreme healthy longevity runs in most of these families, suggesting a heritable basis for this phenomenon. Dr. Milman's team conducts translational research focused on the discovery of genomic mechanisms that regulate endocrine and metabolic pathways that protect against common age-related diseases, like diabetes, cardiovascular disease and Alzheimer's. Dr. Milman became fascinated by both physiology and genetics during her college years and at SUNY Stonybrook School of Medicine, from which she received her medical degree. Following internal medicine residency and fellowship in endocrinology, both at Montefiore, the opportunity arose to combine her passions for physiology and genetics through work with Dr. Nir Barzilai, MD, Director of Institute for Aging Research, the Nathan Shock Center of Excellence in the Biology of Aging, and of the Glenn Center for the Biology of Human Aging at Einstein. During her two years of post-doctoral training in translational gerontology and genetics at Einstein's Institute for Aging Research under Dr. Barzilai's mentorship, she got hooked on the study of aging and found what has become her life's work. Support the show

Pastor Jésus Figureo en el Congreso Aposento 2023.

In today's podcast episode, I talk with Nir Barzilai, a geroscientist, which means he studies the biology of aging. Barzilai directs the Institute for Aging Research at the Albert Einstein College of Medicine.My first question for Dr. Barzilai was: why do we age? And do we have to age? His answers were encouraging. We can't live forever, but there are a few things we can do to age later, as he argues in the book.He explained that centenarians differ from the rest of us because they have unique gene mutations that help them stay healthy longer. For most of us, the words “gene mutations” spell trouble—we associate these words with cancer or neurodegenerative diseases, but apparently not all mutations are bad. Centenarians may have essentially won the genetic lottery, but that doesn't mean the rest of us are predestined to have a specific lifespan and health span—the amount of time spend living productively and enjoyably. “Aging is a mother of all diseases,” Dr. Barzilai told me. And as a disease, it can be targeted by therapeutics. Dr. Barzilai's team is already running clinical trials on such therapeutics—and the results are promising. More about Dr. Barzilai: He is scientific director of AFAR, American Federation for Aging Research. He is also the author of Age Later.  As part of his work, Barzilai studies families of centenarians and their genetics to learn how the rest of us can learn and benefit from their super-aging. He also organizing a clinical trial that is testing a specific drug that may slow aging. Show LinksAge Later: Health Span, Life Span, and the New Science of Longevity  https://www.amazon.com/Age-Later-Healthiest-Sharpest-Centenarians/dp/1250230853American Federation for Aging Research  https://www.afar.orghttps://www.afar.org/nir-barzilaihttps://www.einsteinmed.edu/faculty/484/nir-barzilai/Metformin as a Tool to Target Aginghttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943638/Benefits of Metformin in Attenuating the Hallmarks of Aging  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347426/The Longevity Genes Project https://www.einsteinmed.edu/centers/aging/longevity-genes-project/Leaps.org is a not-for-profit initiative that publishes award-winning journalism, popularizes scientific progress on social media, and hosts events about bioethics and the future of humanity. Visit the platform at www.leaps.org. Podcast host Matt Fuchs is editor-in-chief of Leaps.org.

Oren Barzilai, Founder and CEO of EquityBee Every day professionals miss out on the opportunity to build wealth through stock options and other stock-based compensation. Some professionals might not understand how they work or can't afford to exercise stock options when they leave. Don't miss Oren's master class about stock options and how they might affect your total compensation offer at a startup. https://blindap.onelink.me/ttCg/c2676260

Palavra ministrada na Family Church em Goiânia - GO Barzilai, de Gileade, também saiu de Rogelim, acompanhando o rei até o Jordão, para despedir-se dele. Barzilai era bastante idoso; tinha oitenta anos. Foi ele que sustentou o rei durante sua permanência em Maanaim, pois era muito rico. O rei disse a Barzilai: "Venha comigo para Jerusalém, e eu cuidarei de você". Barzilai, porém, respondeu: "Quantos anos de vida ainda me restam, para que eu vá com o rei e viva com ele em Jerusalém? Já fiz oitenta anos. Como eu poderia distinguir entre o que é bom e o que é mau? Será que hoje o teu servo ainda pode sentir o gosto daquilo que come e bebe? Posso ainda apreciar a voz de homens e mulheres cantando? Eu seria mais um peso para o rei, meu senhor. Teu servo acompanhará o rei um pouco mais, atravessando o Jordão, mas não há motivo para uma recompensa dessas. Permite que o teu servo volte! E que eu possa morrer na minha própria cidade, perto do túmulo de meu pai e de minha mãe. Mas aqui está o meu servo Quimã. Que ele vá com o meu senhor e rei. Faze por ele o que achares melhor! " O rei disse: "Quimã virá comigo! Farei por ele o que você achar melhor. E tudo o mais que desejar de mim, eu o farei por você". Então, todo o exército atravessou o Jordão, e também o rei o atravessou. O rei beijou Barzilai e o abençoou. E Barzilai voltou para casa. 2 Samuel 19:31-39

Dr. Nir Barzilai, MD ( https://www.einsteinmed.edu/faculty/484/nir-barzilai/ ) is the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics. Dr. Barzilai's research interests are in the biology and genetics of aging, with one focus of his team on the genetics of exceptional longevity, where they hypothesize and demonstrate that centenarians (those aged 100 and above) may have novel protective genes, which allow the delay of aging or for the protection against age-related diseases. The second focus of his work, for which Dr. Barzilai holds an NIH Merit award, is on the metabolic decline that occurs during aging, and his team hypothesizes that the brain leads this decline with some very interesting neuro-endocrine connections. Dr. Barzilai is currently leading an international effort to approve drugs that can target aging (Gerotherapeutics). Targeting Aging with METformin (TAME) is a specific study designed to prove the concept that a basket of diseases (multi-morbidities) of aging can be delayed simultaneously, in this protocol by the drug metformin, working with the FDA to approve this approach which will serve as a template for future efforts to delay aging and its diseases in humans. Dr. Barzilai has received numerous grants, among them ones from the National Institute on Aging (NIA), American Federation for Aging Research, the Ellison Medical Foundation and The Glenn Medical foundation. He has published over 280 peer-reviewed papers, reviews, and textbook chapters. He is an advisor to the NIH on several projects and serves on several editorial boards and is a reviewer for numerous other journals. Dr. Barzilai is on the board of the American Federation for Aging Research, is it's co-scientific director, and has served on several NIA study sections. He is also a founder of CohBar Inc., a biotech company that develops mitochondrial derived peptides as therapy for aging and it's diseases, and of Life Biosciences. Dr. Barzilai has been the recipient of numerous prestigious awards, including the Beeson Fellow for Aging Research, the Ellison Medical Foundation Senior Scholar in Aging Award, the Paul F. Glenn Foundation Award, the NIA Nathan Shock Award, the 2010 Irving S. Wright Award of Distinction in Aging Research and the IPSEN Longevity Prize (2016). Born in Israel, Dr. Barzilai served as chief medic and physician in the Israel Defense Forces. He graduated from The Ruth and Bruce Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology in Haifa and completed his residency in internal medicine at Hadassah Medical Center in Jerusalem. He served in a refugee camp during the war in Cambodia (1979-1980) and built a nutritional village in the homeland of the Zulu (1983 – Kwazulu). He has completed 2 fellowships at Yale (Metabolism) and Cornell (Endocrinoology and Molecular Medicine).  He has also taken part in Global initiatives and spoke at The Milken Global Institute, Asian Megatrends and is an advisor for the Prime Minister of Singapore on Aging. Dr. Barzilai has been on the ‘Forward 50, top 50 influence Jews" in the US (2011). His work has been profiled by major outlets, including the New York Times, the BBC and PBS' NOVA science now, TEDMED and several TEDx talks, and is the leading feature on the Ron Howard/Jonathan Silberberg/National Geographic film about the Age of Aging. He also authored the book Age Later (2019). Support the show

What do we know about the process of aging? What makes some people age quicker than others?  How do we prolong our lives? Newt's guest is Dr. Nir Barzilai. He is a Professor in the Department of Medicine and the Department of Genetics at Albert Einstein College of Medicine.  He is also the Director of the Institute for Aging Research. In the “Longevity Genes Project”, Dr. Barzilai and his team conducted genetic research on more than 500 healthy elderly people between the ages of 95 and 112 and on their children. He is the author of “Age Later: Health Span, Life Span, and the New Science of Longevity.” See omnystudio.com/listener for privacy information.

A rare MD at the cutting edge of the longevity field, Dr. Barzilai heads the Institute for Longevity Research at Einstein. We cover his unique contributions, especially the currently buzzy topic of metformin, as well as his work on the genetic luck of centenarians.

Barzilai, de Gileade, também saiu de Rogelim, acompanhando o rei até o Jordão, para despedir-se dele. Barzilai era bastante idoso; tinha oitenta anos. Foi ele que sustentou o rei durante sua permanência em Maanaim, pois era muito rico. O rei disse a Barzilai: "Venha comigo para Jerusalém, e eu cuidarei de você". Barzilai, porém, respondeu: "Quantos anos de vida ainda me restam, para que eu vá com o rei e viva com ele em Jerusalém? Já fiz oitenta anos. Como eu poderia distinguir entre o que é bom e o que é mau? Será que hoje o teu servo ainda pode sentir o gosto daquilo que come e bebe? Posso ainda apreciar a voz de homens e mulheres cantando? Eu seria mais um peso para o rei, meu senhor. Teu servo acompanhará o rei um pouco mais, atravessando o Jordão, mas não há motivo para uma recompensa dessas. Permite que o teu servo volte! E que eu possa morrer na minha própria cidade, perto do túmulo de meu pai e de minha mãe. Mas aqui está o meu servo Quimã. Que ele vá com o meu senhor e rei. Faze por ele o que achares melhor! " O rei disse: "Quimã virá comigo! Farei por ele o que você achar melhor. E tudo o mais que desejar de mim, eu o farei por você". Então, todo o exército atravessou o Jordão, e também o rei o atravessou. O rei beijou Barzilai e o abençoou. E Barzilai voltou para casa. 2 Samuel 19:31-39

Barzilai é um exemplo de amizade verdadeira, provada e comprovada. Quando Davi, ainda ameaçado de perder o trono, esteve em sua terra, foi por ele sustentado. Acalmada a situação, o rei começa o caminho de volta para Jerusalém e convida Barzilai para o acompanhar. Davi queria retribuir o que recebera. Só que Barzilai não fez o que fez motivado por uma eventual recompensa. Por isso, recusa-se a aceitar o presente, certo de que, por sua idade e saúde, pouco aproveitaria. No entanto, antes de voltar para casa, sugeriu que o prêmio fosse transferido para um empregado (Quimã). Davi concordou. Deu-lhe um beijo e seguiu seu caminho. Quando precisarem de nós, devemos seguir o exemplo de Barzilai e seus amigos. 1. Devemos prestar atenção. Para prestar atenção, precisamos aprender (sim, é uma aprendizagem) a olhar menos para nós mesmos. Barzilai era idoso (80 anos) e não estava nas melhores condições para ajudar. Não gozava de boa saúde (versículo 35). A generosidade não depende de nossas condições ideais, que talvez jamais cheguem. Por menos que tenhamos, sempre temos o que repartir. Cuidemos para que a posse de bens (ou de conhecimento) não nos torne insensíveis à necessidade do outro. 2. Devemos pressupor que a dificuldade do outro é nossa dificuldade. Antecipemo-nos, porque nem sempre seremos exigidos (por timidez ou vergonha do outro, necessitado). Davi vivia um drama de família; fugia porque seu filho tentava tomar o controle do governo (1Reis 2.7). 3. Devemos nos pôr em ação. Barzilai desceu de sua cidade para se encontrar com Davi. Ação às vezes exige sacrifício. Barzilai passou o rio. Fez fez mais: atravessou o rio com o grupo de Davi. Fez mais ainda: como sua condição permitia, sustentou Davi e sua equipe. E Barzilai fez tudo isso sem qualquer perspectiva de retorno. Não fez para receber; simplesmente fez. Não esperou gratidão. É assim que a nossa generosidade deve se manifestar. AZEVEDO, Israel Belo de - Bíblia Sagrada Bom Dia

Dovid's instructions regarding Yoav, Barzilai's children and Shimi

================================================== ==SUSCRIBETEhttps://www.youtube.com/channel/UCNpffyr-7_zP1x1lS89ByaQ?sub_confirmation=1================================================== == DEVOCIÓN MATUTINA PARA JÓVENES 2022“EJEMPLOS Y ENSEÑANZAS DE LAS ESCRITURAS”Narrado por: Daniel RamosDesde: Connecticut, Estados UnidosUna cortesía de DR'Ministries y Canaan Seventh-Day Adventist Church   19 DE AGOSTO UNA CUALIDAD DIVINABarzilay era ya muy anciano, pues tenía ochenta años, y cuando el rey estuvo en Majanayin él le había dado provisiones, pues era muy rico (2 Samuel 19: 32).«CUÁNTOS HAY QUE AHORA MISMO [...] Viven día tras día, semana tras semana, año tras año para sus propios intereses egoístas. Su influencia y sus recursos, acumulados a través de la capacidad y el tacto que Dios le ha dado, los usan para ellos mismos y sus familias sin pensar en su bondadoso Benefactor. No permitan que nada fluya de vuelta al Dador» (Elena G. White, La edad dorada , p. 94).Desde que entró el pecado, el egoísmo fue una constante en la vida humana. Siendo Satanás el primer gran egoísta del universo, este rasgo detestable forma parte de la «genética» del hombre. Pero, en las Escrituras, tenemos varios ejemplos de hombres que mostraron ser diferentes y fueron solidarios con sus semejantes.Este fue el caso de Barzilai, un venerable anciano, sumamente rico, que sintió la compasión de David mientras huía de Jerusalén.Para el perseguido rey, todo parecía perdido. El pueblo de Israel parecía estar del lado de Absalón, ese joven de hermoso parecer que durante años se había propuesto ocupar el trono de su padre. David, como hombre experimentado, conocía las consecuencias de una insurrección, por eso abandonó su querida ciudad para que no corriera sangre inocente.Mientras huía, Barzilai salió a su encuentro y le entregó provisiones al rey cuando estaba en Mahanaim. Jamás esperó una recompensa, ya que todo parecía mostrar que Absalón sería el nuevo rey. Su generosidad fue espontánea y sincera, y luego de que David recuperara el trono, el rey procuró recompensar a Barzilai por su dadivosidad. El anciano generoso con la oferta,Si bien todos conocemos la gran verdad que dice: «Porque nada hemos traído a este mundo, y sin duda nada podremos sacar» (1 Tim. 6:7), aun así, miles luchan, se estresan y hasta se enferman por acumular riquezas que en cinco vidas no podrian gastar. Por eso, el ejemplo de Barzilai y el consejo bíblico es claro: todo lo que poseemos procede de un Dios generoso, e imitando esta cualidad divina, se nos invita a compartir algo de lo que poseemos con nuestros semejantes. Si lo hacemos, escucharemos la recompensa de labios de Jesús que nos dirá: «De cierto les digo que todo lo que hicieron por uno de mis hermanos más pequeños, por mí lo hicieron» (Mat. 25: 40),

Today's pages of Talmud, Yevamot 76 and 77, tell us about a man named Barzilai who was so licentious, he would get aroused merely by looking at a woman's dress. What can this Talmudic dude teach us about the pitfalls of Internet pornography? And what dangers do we face when we turn the holy work of sexual arousal into something fast, flat, cheap, and dirty? Listen and find out. Like the show? Send us a note at takeone@tabletmag.com. Follow us on Twitter at @takeonedafyomi and join the conversation in the Take One Facebook group. Take One is a Tablet Studios production. The show is hosted by Liel Leibovitz, and is produced and edited by Darone Ruskay and Quinn Waller. Our team also includes Stephanie Butnick, Josh Kross, Mark Oppenheimer, Sara Fredman Aeder, Robert Scaramuccia, and Tanya Singer.  Check out all of Tablet's podcasts at tabletmag.com/podcasts. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr Nir Barzilai is Professor and Founding Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Essentially he is an OG (original gangster) in human longevity research. When describing him, David Sinclair writes “Not only is he a world leader in aging research, but also happens to be one of the best science communicators on the planet”. Barzilai is also the author of Age Later: Secrets of the Healthiest, Sharpest Centenarians. He has over 270 peer reviewed papers and also co-founded CohBar, a publicly listed biotech company developing mitochondrial therapies for ageing. In his quest to fight ageing — he has consulted or presented to institutions such as the Vatican, PepsiCo and Singapore's Prime Minister's Office. He also leads the TAME Trial which is looking at a cheap and commonly used diabetes drug called Metformin — to see if it can slow down the process of ageing. Metformin first gained interest in the longevity space, when people began to notice that diabetics on metformin seemed to have lower mortalities than diabetes on other drugs. In fact, diabetics on metformin had lower death rates than similar people — who didn't have diabetes and so were not on metformin. Just to be clear, diabetics on metformin with a serious medical condition — which is one of the big four killers in the developed world — appear to have lower death rates than non-diabetics who aren't taking metformin. That's crazy. In his TAME trial he's investigating if metformin can delay the progression of age related diseases in older adults. Barzilai is part of a movement in longevity research or geroscience, who aim to treat ageing as a disease in itself — instead of treating one disease, only for another to take its place. In a 1990 paper in Science, it was estimated that if we cured all cancers — we would extend the average lifespan by just three years. That's not to say that developing therapies for cancers is wrong, but to really move the needle on health and lifespan extension — we need to think of tackling ageing and not just individual manifestations of ageing such as cancer, diabetes, heart disease and Alzheimers. You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

En este episodio Axel nos comparte la importancia de poder estar abiertos a experimentar lo que sea que se presente dentro de cada experiencia ya que es lo que la vida nos presenta momento a momento. La clave esta en usar esas experiencias para conocernos y para crecer. Si este contenido aporto algo a tu vida, no olvides darle like, suscribirte y compartirlo con tus seres queridos. También disponible en Youtube. Redes sociales de Axel: IG @axelbarzilai IG @lightprojection 00:00 INTRODUCCION 02:00 LA VIDA COMO BUFFET DE EXPERIENCIAS 04:37 PERMITETE VIVIR LA EXPERIENCIA 06:50 TODOS PODEMOS HACERLO 07:19 LOS FILTROS DE LA REALIDAD 09:00 LA HONESTIDAD 16:33 LA RESPONSABILIDAD 18:05 LO QUE INSPIRA A QUERER CRECER 19:32 SENTIR LO QUE ES INCOMODO 20:22 COMO USARLO PARA CRECER 21:00 AMOR VS MIEDO 22:30 INTEGRAR MIS PARTES 23:38 ABRAZAR SIN EMPUJAR 26:16 LA CLAVE DE LAS RELACIONES SANAS 28:12 CADA QUIEN TIENE SU PROCESO 31:58 LAS POLARIDADES DE LA VIDA 33:28 ALAN WATTS Y LOS SUEÑOS 35:17 LA EXPERIENCIA COMPARTIDA 37:55 USAR TUS FILTROS COMO MAPA 40:47 PSICOLOGIA ORIENTAL VS OCCIDENTAL 42:30 LA IMPORTANCIA DE OBSERVAR 48:58 APLICA EL APRENDIZAJE 52:10 LA ILUSION DE LA SUPERIORIDAD 53:45 AGRADECIMIENTO Y REDES DE AXEL

Nir Barzilai, M.D. is the director of the Institute for Aging Research at the Albert Einstein College of Medicine. He is also the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Dr. Barzilai's research interests are in the biology and genetics of aging. He is currently leading an international effort to approve drugs that can target aging. Targeting Aging with METformin (TAME) is a specific study designed to prove the concept that multi-morbidities of aging can be delayed by metformin, working with the FDA to approve this approach which will serve as a template for future efforts to delay aging and its diseases in humans. Nir and I Discussed: What is Metformin and what was it previously used for? What does he mean by "cure aging"? Why do your chances of getting sick increase as you grow old Why do women live longer The longevity effects of intermittent fasting How to decipher between good & bad information Can we really extend human life to 200 years or more? And much more... Nir Barzilai My Take: Technology has allowed us all the luxuries that we currently enjoy. Our food, transportation, entertainment, clothes, medicine, communication - and everything else we can think of. Can technology extend human life? Well, it already has. 100 years ago the median age was half what it is now. It will be interesting to see what science will accomplish in the next few years, or decades, with age-related diseases and human longevity. How To Start A Podcast Support The Podcast

Barzilai expresses his desire to remain behind to be buried in his ancestral cemetery

Barzilai declines Dovid's offer due to his advanced age.

Thanks to the application of data and scientific rigor, remarkable gains are being made against one of mankind's most formidable foes: aging. Today's guest is Dr. Nir Barzilai, the founding director for the Institute of Aging Research. In his conversation with host Gregg Fisher, Barzilai breaks down the latest insights in our treatment of the human aging process. Dr. Barzilai distinguishes biological age from chronological age, sharing that the actual number of years healthy human beings are designed to spend on earth is much greater than you think.

This week we take a look at how things are developing on the women's side! A great interview with Aaron Barzilai. one of our Naismith Board of Selectors, from Herhoopstats.com breaking down all the happenings with the conferences! WANT TO SUPPORT A TROPHY LIFE?Leave a rating and review on iTunes, Spotify, or wherever you get your podcasts. Your feedback only helps make the show better, and we appreciate your support!For more information about the Naismith Trophy Award, visit our home on the web.http://naismithtrophy.com/This Episode's SponsorsJersey Mike's

Welcome to Times Will Tell, the weekly podcast from The Times of Israel. This week, ToI published an article about a fascinating study that pinpoints when and where early modern man met up with their Neanderthal cousins -- 50,000 years ago in the Negev Desert. The multi-disciplinary study was authored by the Israel Antiquities Authority and the Weizmann Institute and draws on hi-tech carbon-14 dating, alongside the discovery of material culture excavated by IAA prehistorian, Dr. Omry Barzilai, at the Boker Tachtit site in the Negev. Barzilai explains his path into the world of prehistoric archaeology and helps put a human face on early man, whom he firmly believes were a lot like us. For more on the new study, see: Prehistoric man lived with and loved Neanderthals in the Negev 50,000 years ago IMAGE: Prehistorian Dr. Omry Barzilai. (Courtesy) See omnystudio.com/listener for privacy information.

Age Later: Health Span, Life Span, and the New Science of Longevity In Age Later Dr. Barzilai's New Book - https://amzn.to/30MOsGT Aging and Centenarian Studies : This is the part 2 of our interview series with Dr. Nir Brazilai from Albert Einstein College of Medicine. Dr. Barzilai is the founding director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Dr. Barzilai discovered the first longevity gene in humans and has since discovered several others. In addition to his “longevity gene” research, Dr. Barzilai studies key mechanisms involved in the biology of aging, including how nutrients and genetics influence lifespan. He is also investigating the physical and mental declines associated with aging and how they affect longevity. He is the author of over 270 peer-reviewed papers and a recipient of numerous prestigious awards,including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. Dr. Barzilai's New Book - Age Later: Health Span, Life Span, and the New Science of Longevity In Age Later, the No.1 Best Sellers in Physiology section in Amazon, reveals the secrets his team has unlocked about SuperAgers and the scientific discoveries that show we can mimic some of their natural resistance to the aging process. In this interview Dr. Barzilai discusses his Metformin, rapamycin and the TAME trial, a large scale clinical trial of Metformin to see if it can reduce or delay the effects of aging. Health claims Disclosure: Information provided on this video is not a substitute for direct, individual medical treatment or advice. It is the responsibility of you and your healthcare providers to make all decisions regarding your health. Products or services mentioned in this video are not a recommendation. Disclosure: Some of the links provided are affiliate links. Although we may receive a small commission from the affiliate, the cost of the product for you will always be the same, or often discounted. Thank you for supporting our channel!

Age Later: Health Span, Life Span, and the New Science of Longevity In Age Later Dr. Barzilai's New Book - https://amzn.to/30MOsGT Aging and Centenarian Studies : This is the part 3 of our interview series with Dr. Nir Brazilai from Albert Einstein College of Medicine. Dr. Barzilai is the founding director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Dr. Barzilai discovered the first longevity gene in humans and has since discovered several others. In addition to his “longevity gene” research, Dr. Barzilai studies key mechanisms involved in the biology of aging, including how nutrients and genetics influence lifespan. He is also investigating the physical and mental declines associated with aging and how they affect longevity. He is the author of over 270 peer-reviewed papers and a recipient of numerous prestigious awards,including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. Dr. Barzilai's New Book - Age Later: Health Span, Life Span, and the New Science of Longevity In Age Later, the No.1 Best Sellers in Physiology section in Amazon, reveals the secrets his team has unlocked about SuperAgers and the scientific discoveries that show we can mimic some of their natural resistance to the aging process. In this video Dr. Barzilai draws on his long experience working in the aging field to talk about some of the ways that we can improve our healthspan. His data provides some, perhaps, surprising advice on the ideal BMI and exercise with metformin. Health claims Disclosure: Information provided on this video is not a substitute for direct, individual medical treatment or advice. It is the responsibility of you and your healthcare providers to make all decisions regarding your health. Products or services mentioned in this video are not a recommendation. Disclosure: Some of the links provided are affiliate links. Although we may receive a small commission from the affiliate, the cost of the product for you will always be the same, or often discounted. Thank you for supporting our channel!

Charlie Creme & Aaron Barzilai LinkTree:  https://linktr.ee/NBNwithDA Host: Debbie Antonelli   In this episode, of Nothing But Net with Debbie Antonelli, Debbie is joined, for a second time, by ESPN Women's Basketball Bracketologist Charlie Creme and Founder of Her Hoop Stats, Aaron Barzilai. Last time it was all about the Brackets, this time the trio breakdown everything about the Sweet 16. Predictions, Analysis, Over/Under and Analytics, this episode has everything you will need to prepare for what should be an AWESOME ride from the Sweet 16 all the way to the National Championship! Be sure to listen and subscribe to Nothing But Net with Debbie Antonelli, so you will never miss a future episode!   E-Mail your questions to Debbie at AskAntonelli@gmail.com for our weekly segment of #AskAntonelli. 

Age Later: Health Span, Life Span, and the New Science of Longevity In Age Later Dr. Barzilai's New Book - https://amzn.to/30MOsGT Aging and Centenarian Studies : This is the part 1 of our interview series with Dr. Nir Brazilai from Albert Einstein College of Medicine. Dr. Barzilai is the founding director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Dr. Barzilai discovered the first longevity gene in humans and has since discovered several others. In addition to his “longevity gene” research, Dr. Barzilai studies key mechanisms involved in the biology of aging, including how nutrients and genetics influence lifespan. He is also investigating the physical and mental declines associated with aging and how they affect longevity. He is the author of over 270 peer-reviewed papers and a recipient of numerous prestigious awards,including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. Dr. Barzilai's New Book - Age Later: Health Span, Life Span, and the New Science of Longevity In Age Later, the No.1 Best Sellers in Physiology section in Amazon, reveals the secrets his team has unlocked about SuperAgers and the scientific discoveries that show we can mimic some of their natural resistance to the aging process. In this interview Dr. Barzilai discusses his study of centenarians, what he learnt from that and how it can be applied. By studying centenarians and the mechanisms that keep them healthy he hopes to short cut years research and animal trials. Health claims Disclosure: Information provided on this video is not a substitute for direct, individual medical treatment or advice. It is the responsibility of you and your healthcare providers to make all decisions regarding your health. Products or services mentioned in this video are not a recommendation. Disclosure: Some of the links provided are affiliate links. Although we may receive a small commission from the affiliate, the cost of the product for you will always be the same, or often discounted. Thank you for supporting our channel!

Nir Barzilai shares his expertise on how ageing can be targeted and reversed. Dr Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Centre in the world to study the Biology of Ageing, Institute for Aging at The Albert Einstein College of Medicine.

We couldn't have left Israel without visiting Karamba Security headquarters in Hod Hasharon! That's where Cédric met with chairman & co-founder, David Barzilai, and discussed various gripping topics like the autonomous driving opportunities, car hacking as well as building an “A team”. Don't miss this episode!David Barzilai is an entrepreneurial executive, with a wealth of experience in contributing to established companies as a VP Marketing and Management Advisor. When talking about his career, he illustrates it as a mixture of startup entrepreneur and go-to-market executive. Also, what excites Barzilai the most about the startup world is the impact and the change that can be made. In our interview with this serial entrepreneur, the main focus was on the third company he co-founded, Karamba Security.With the rise of self-drive vehicles and all the benefits that come along, there is also a rising risk of cyber attacks. Karamba Security is a cybersecurity company that provides preventive solutions for the automotive industry. Barzilai explains that data centre cybersecurity use the quite common methodology of false alerts, based on statistics and heuristics. Since statistics is not always right, the team behind Karamba Security was the first to come up with a solution that enables prevention with zero false alerts. Website https://karambasecurity.com/If you are curious about IoT and you would like to get a deeper insight into the challenges of autonomous driving, click the video below! Additionally, you will learn what to look for in an investor and how Barzilai managed to turn a failure into a great learning experience. Enjoy!Skip to Questions:0:58 Who is David Barzilai?1:38 What excites you about being in entrepreneurship?2:59 What is Karamba Security?6:58 What are the biggest reasons for slow autonomous driving adoption?7:55 How is cyber security development different than other software development?10:07 How did you identify that the market needs your product?13:20 What is your experience with presenting to bigger markets (like the USA) as a small company from Israel?15:09 What is your experience with the Israel startup ecosystem? What are your impressions? Q&A16:52 What would you like to see in the next five years in your ecosystem?16:59 What traits do you look for when you hire someone?17:59 Do you have a story of how you turned a failure into a learning experience?20:12 What's important to you in an investor?Expert Advice21:19 Expert Advice from David Barzilai——————————————Cédric Bollag is an aspiring venture capitalist. Cédric decided to turn his passion about “Startups, Tech & Innovation” into a blog. He releases video interviews with entrepreneurs, investors and thought leaders in innovation. For any questions, suggestions and inquiries feel free to connect and reach out.Connect with me on other social media channels:Cédric Bollag (Blogger & Founder):Email: cedric@globaltechbox.comInstagram: https://www.instagram.com/cedric.bollag/Snapchat: https://www.snapchat.com/add/cedric.b...Facebook: https://www.facebook.com/cedric.bollag/LinkedIn: https://www.linkedin.com/in/cedricbol...GlobalTechBox.com:Instagram: https://instagram.com/globaltechbox/Snapchat: https://www.snapchat.com/add/globalte...Facebook: https://www.facebook.com/globaltechbox/Thank you for your attention! Hosted on Acast. See acast.com/privacy for more information.

Netanyahu breaks silence on Khashoggi During a news conference in Bulgaria on Friday, Prime Minister Benjamin Netanyahu finally broke his silence regarding the murder of Saudi journalist Jamal Khashoggi. Netanyahu was quoted saying “what happened in the Istanbul consulate was horrendous and it should be duly dealt with." U.S. increases sanctions on Iran The United States is now gearing up to impose its second set of harsh sanctions against the hardline Islamic Regime since the U.S. dropped out of the Iranian JCPOA nuclear deal last may. This time, the Trump Administration will be more specifically targeting the Iranian oil industry. 3. U.S. increases sanctions on Iran Dr. Mordechai Kedar, Begin-Sadat Center for Strategic Studies, Bar Ilan University speaking at ILTV Studio about the second round of resumed punitive that is set to go into effect tomorrow. Hamas & Israel near ceasefire deal Hamas and Israel are reportedly closer than ever to a ceasefire agreement today as Hamas-affiliated newspaper Al Akhbar, in Lebanon, published a preliminary look at the alleged deal. In it, ten provisions are spelled out each of which creates the conditions for the clauses that follow. Rifles for rabbis? It's now been a week since the massacre at the tree-of-life synagogue, of Squirrel Hill Pittsburgh and the toll it has taken especially on the Jewish community but indeed also on all faiths around the country is still being felt. ILTV correspondent Yael Shir is here with the update. U.K. police open investigations into Labor Party After months and months of accusations, British police have now announced to the BBC that they have opened an investigation into allegations of criminal Anti-Semitism within the UK Labour party. Police reiterate that the party itself is not under investigation though many individuals within the party are. 7. LGBT surrogacy bill fails to advance in Knesset In spite of heavy demonstrations and a practically split parliament, the Israeli Knesset rejected the preliminary reading of a bill that would include same sex couples in existing surrogacy laws. The draft legislation was a combination of two proposals put forth by Zionist Union MK Itzik Shmuli and Yesh Atid's Yael German. Bedouin women strive for equality The practice of a polygamous marriage became criminalized in Israel in 1977 and is punishable by up to 5 years in prison but for Bedouin communities, the law simply has not been enforced, well now Israel wants Bedouin women to strive for equality and end polygamy within their communities and ILTV correspondent Doriel Mizrachi is here with more about it. 23rd anniversary of Yitzhak Rabin's death Today marks the 23rd anniversary of the death of Prime Minister Yitzhak Rabin.  Thousands gathered in Tel Aviv's Rabin square over the weekend to commemorate his death and the event was organized by the Darkenu movement and the national union of Israeli students. 10. ‘I'm not your toy' singer headed back to Europe Ever since the competition's end, Israel's winner Netta Barzilai has been preparing for this day. Barzilai is now headed to Europe for her first Euro-world tour and ILTV'S Emanuelle Kadosh has all the details... 11. Hebrew word Of The Day: PONDEKAUT | פונדקאות= SURROGACY Learn a New Hebrew word every day. Today's word is "pondekaut" which means "surrogacy" See omnystudio.com/listener for privacy information.

Bolton meets with Netanyahu President Trump's Top National Security Adviser, John Bolton, arrived in Israel yesterday afternoon for talks with Prime Minister Netanyahu. At the very top of the agenda is a frank discussion on the Iranian threat entrenched throughout Syria, a threat both nations want to see immediately resolved. Details of Jordan's White House visit revealed Six weeks ago the king of Jordan made a trip to the White House for a one-on-one talk with U.S. President Donald Trump. A new account of the details of that meeting has just emerged, with some surprising comments concerning Trump's thoughts on Israeli-Palestinian peace. Sodastream sells big to Pepsi Dan Catarivas, Director General of Foreign Trade, M.A.I. speaking at ILTV Studio about the Israeli company Sodastream that was sold for whopping $3.2 billion to Pepsico. Ariel University opens med school Israeli leaders just rolled out the red carpet for the inauguration of Ariel University's new medical school. The school's patrons, Sheldon and Miriam Adelson were there to receive the warm words of President Reuven Rivlin and Education Minister Naftali Bennett. The new med school will welcome its first class of 70 future doctors this coming fall semester. Beloved Israeli Peace Activist passes away Some tragic news today. Beloved peace activist and former Knesset member Uri Avnery has just passed away at the age of 94, following a severe stroke. Though known as a leading figure of Israel's left-wing movement and as a champion of Palestinian statehood, Israeli leaders from across the spectrum have offered their condolences. Israeli OCD treatment makes waves Another potentially groundbreaking Israeli medical treatment has just been approved for use in the United States by the F-D-A. This new treatment is a cutting-edge, non-invasive procedure to help patients struggling with obsessive compulsive syndrome better known as O-C-D. No lice allowed! Doron Kenigsbuch, Founder & C.E.O., Sphinx Smarthead Technologies speaking at ILTV Studio about the Sphinx smart head technologies that offers new head lice treatment. Israeli athlete clinches 2nd gold medal Another day, another impressive entry in Israeli sports history. 19 year-old gymnast Linor Ashram has just stunned audiences in Minsk at the Rhythmic Gymnastics World Challenge Cup, winning two gold medals, one bronze and oh yeah, shattering a world record while she's at it. 9. Lana Del Rey is not backing out Over the years, all kinds of performers have booked appearances in Israel only to back out later due to political or social pressure. Singer Lana Del Rey has just booked a headlining show at this year's meteor festival to take place in Israel just weeks away. ‘Toy' is top of the pops It just wouldn't be a news day in Israel if there wasn't an update on Israeli superstar Netta Barzilai but this news might just take the cake: Barzilai's hit song “toy” has just graced billboard's top dance club tracks at number one. The first time any Israeli performer has ever done so. 11. Hebrew word Of The Day: HIT'AMLUT | הִתעַמְלוּת = GYMNASTICS Learn a New Hebrew word every day. Today's word is "hit'amlut" which means "gymnastics" See omnystudio.com/listener for privacy information.

Netanyahu seeks compromise deal Last-minute talks with Netanyahu and Ultra-Orthodox parties have reached a temporary compromise, though the Prime Minister has struck a deal to appease the Orthodox faction of his coalition by exempting Haredim from the I.D.F, it remains to be seen if the rest of the government will agree. Netanyahu seeks compromise deal Naphtali Bensimon, Likud Party speaking at ILTV Studio about the last minute talks delay early elections, and a closer look at the political turmoil in Jerusalem. 3. Two countries prep embassy move to Jerusalem Sources have named Paraguay and Honduras as next in line for the move of their embassies from Tel Aviv to Jerusalem, though neither country has officially confirmed these reports. P.A. officials respond to calls to take Trump plan Following recent Palestinian criticisms of the Arab world, P.A. President Mahmoud Abbas has now reportedly ordered his administration to keep silent or face the consequences. Proud to be a bookworm Israeli authors like Amos Oz and David Grossman are considered some of the top literary minds of the modern era, and while they were born in Jerusalem, it comes as no surprise that Tel Aviv has just been named one of the top ten literary cities in the world Virtually addressing teen mental health Iftach Weiser, Managing Partner Of Openmind 360° speaking at ILTV Studio about the Israeli company that uses V.R. technology workshops to reduce anxiety; stress. 7. Is a housing crisis on the horizon? The world's leading economic group, the O.E.C.D., has just given Israel its annual economic report card, and while the Jewish state earned high marks when it comes to overall growth, things could take a turn for the worse if the housing bubble bursts. Israeli backpackers become ‘heroes for life' Three years ago, twenty year-old Danielle Sonnenfeld, was tragically killed in a car accident while living in Israel. In honor of her memory, an Israeli non-profit group called ‘Heroes For Life' has just sent twenty-five Israeli backpackers on a very special mission. Meet the Israeli who's hacking the world's genes Yaniv Erlich, better known as the “Genome Hacker”, has just assembled a family tree connecting thirteen million people. Donations made easy! Shimi Uhlman, Founder & CTO Of Truegive speaking at ILTV Studio about the Israeli Startup that has found a way to make donating to causes much easier. Kristen Wiig set to costar in Wonder Woman 2 The Israeli superstar Gal Gadot has some exciting news for us, SNL Veteran -Kristen Wiigs is set to Co Star in the upcoming wonder woman movie. 12. Israeli singer Ain't Your ‘Toy' In just a few short months, Israeli Superstar Netta Barzilai heads to Portugal to rep Israel in the 2018 Eurovision competition. Israeli media has just released a preview of the song Barzilai will sing. Hebrew word Of The Day: MIT'MODED | מתמודד = CONTESTANT Learn a New Hebrew word every day. Today's word is "Mit'moded" which means "Contestant" The Weather Forecast The skies will be partly cloudy tonight, but temperatures should rise to a low of fifty-two or eleven degrees Celsius. Tomorrow you can expect clear skies and little to no change in temperatures. The high will sit around seventy, or twenty-one degrees Celsius. See omnystudio.com/listener for privacy information.

  There's a great community of data scientists on the Internet and that's how I originally came across Aaron Barzilai. Now Aaron has launched herhoopstats.com, a site that aspires to be the Ken Pom of women's college basketball. Since Richard Deitsch is so knowledgeable about women's college hoops I asked him to join in. Topics discussed include: — the path from advanced degrees in mechanical engineering to data analytics. —...